Biolegend, 323205, PE anti-human CD105 Antibody, 25tests

CD105 is also known as Endoglin. It is a type I integral membrane homodimer protein with subunits of 90 kD found on vascular endothelial cells and syncytiotrophoblasts of placenta. CD105 is weakly expressed on stromal fibroblasts. It is also expressed on activated monocytes and tissue macrophages. Expression of CD105 is increased on activated endothelium in tissues undergoing angiogenesis, such as in tumors, or in cases of wound healing or dermal inflammation. CD105 is a component of the TGF-β receptor system in human umbilical vein endothelial cells and binds TGF-β1 and β3 with high affinity but does not bind to TGF-β2.
25tests
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: L-cells transfected with human CD105
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application References(PubMed link indicates BioLegend citation): Bühring HJ, et al. 1991. Leukemia 5:841. Vogel W, et al. 2002. Haematologica 88:126. Osaka M, et al. 2011. Brain Res. 9:1343. PubMed HonMou O, et al. 2011. Brain. 134:1790. PubMed Herrera MB, et al. 2013. Hepatology. 57:311. PubMed Iohara K, et al. 2014. Exp Gerontol. 52:39. PubMed
Product Citations: Melzer C, et al. 2020. Int J Mol Sci. :21. PubMed Kim SW, et al. 2018. Adv Sci (Weinh). 5:1700860. PubMed Wu J, et al. 2020. Cell Res. 30:794. PubMed Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed Tamaoki N, et al. 2023. Cell Rep Methods. 3:100460. PubMed Park J, et al. 2021. Exp Ther Med. 22:808. PubMed Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed Sonoda S, et al. 2022. STAR Protoc. 3:101386. PubMed Liu C, et al. 2022. Regen Ther. 21:192. PubMed Costa MHG, et al. 2021. Biotechnol J. 16:e2000389. PubMed Labedz-Maslowska A, et al. 2021. Cells. 10: . PubMed Polisetti N, et al. 2022. Bio Protoc. 12: . PubMed Robb KP, et al. 2022. Front Immunol. 13:972095. PubMed Herrera M, et al. 2013. Hepatology. 57:311. PubMed Lee JK, et al. 2020. Sci Rep. 2.567361111. PubMed Liu X, et al. 2020. Exp Ther Med. 1.258333333. PubMed Shi L, et al. 2021. Stem Cell Res Ther. 12:147. PubMed Huang X, et al. 2019. Oxid Med Cell Longev. 2019:1305049. PubMed Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed Zhang B, et al. 2022. Stem Cells Int. 2022:2236250. PubMed Nowak WN, et al. 2019. Mediators Inflamm. 2019:1868170. PubMed Ali S, et al. 2018. Purinergic Signal. 14:371. PubMed Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed Sun W, et al. 2019. Exp Ther Med. 17:2199. PubMed Liu W, et al. 2018. Theranostics. 8:5575. PubMed Zhang J, et al. 2022. Int J Mol Sci. 23:. PubMed Liu Y, et al. 2022. iScience. 25:104405. PubMed Schupp J, et al. 2021. Int J Mol Sci. 22:00. PubMed Lance R Thurlow et al. 2018. Journal of cellular biochemistry. 120(6):9213-9229 . PubMed Zhang Y, et al. 2019. Aging (Albany NY). 11:12641. PubMed Honmou O, et al. 2011. Brain. 134:1790. PubMed Lee JK, et al. 2021. Cells. 10:. PubMed Xu L, et al. 2022. Int J Mol Sci. 23:. PubMed Mithal A, et al. 2020. Nat Commun. 0.607638889. PubMed He H, et al. 2019. J Cell Mol Med. 23:4139. PubMed Wang W, et al. 2022. Int J Mol Sci. 23:. PubMed Labedz-Maslowska A, et al. 2020. Int J Mol Sci. 21:. PubMed Iohara K, et al. 2014. Exp Gerontol. 52:39. PubMed Matheni C, et al. 2021. Cell J. 23:145. PubMed Pan C, et al. 2019. Int J Mol Med. 44:1629. PubMed Hong Y, et al. 2020. Aging Cell. 19:e13128. PubMed Henson F, et al. 2021. J Orthop Res. 39:1411. PubMed Honmou O, et al. 2011. Brain. 1.307638889. PubMed Wang G, et al. 2018. Int J Mol Med. 41:791. PubMed Khanh VC, et al. 2021. Stem Cells Dev. 30:758. PubMed
RRID: AB_755957 (BioLegend Cat. No. 323205) AB_755958 (BioLegend Cat. No. 323206)
Structure: Associates with TGF-ß receptor I and II, homodimeric type I integral membrane protein, 90 kD
Distribution: Endothelial cells, activated monocytes/macrophages, bone marrow stromal cells, hematopoietic stem/progenitor cells
Function: Modulates cellular response to TGF-ß, involved in vascular development and remodelling
Ligand/Receptor: TGF-ß1, TGF-ß3
Cell Type: Endothelial cells, Hematopoietic stem and progenitors, Macrophages, Mesenchymal Stem Cells, Monocytes
Biology Area: Angiogenesis, Cell Biology, Immunology, Stem Cells
Molecular Family: Adhesion Molecules, CD Molecules
Antigen References: 1. Mason D, et al. Eds. 2002. Leucocyte Typing VII. Oxford University Press. New York. 2. Pierelli L, et al. 2001. Leuk. Lymphoma 42:1195.
Gene ID: 2022
UniProt: View information about CD105 on UniProt.org
Clone: 43A3
Regulatory Status: RUO
Other Names: Endoglin
Isotype: Mouse IgG1, κ
Q: What type of PE do you use in your conjugates?
A: We use R-PE in our conjugates.